Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
383 rows where has_cryoEM = 1, in_cev_map = 0 and surface_class = "B_cargo" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: aptamer_count_pubmed
surface_class 1
- B_cargo · 383 ✖
in_cev_map 1
- - · 383 ✖
has_structure 1
- 1 383
has_cryoEM 1
- 1 · 383 ✖
has_activation_state_pdb_pair 1
- 0 383
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q13315 | ATM | Serine-protein kinase ATM | Tier 1 | 0.613 | 1 | B_cargo | 14 | 1 | 0 | 1 | 9 | 41867498, 39253616, 37656667, 34733968, 28838608, 28706912, 26176230, 17386435, 15181173 | 0 | ataxia telangiectasia | 0.8759719859489208 | |||
| P35670 | ATP7B | Copper-transporting ATPase 2 | Tier 1 | 0.61 | 1 | B_cargo | 13 | 71.69 | 1 | 0 | 1 | 1 | 39737993 | 0 | Wilson disease | 0.8657500553466239 | ||
| O43602 | DCX | Neuronal migration protein doublecortin | Tier 1 | 0.609 | 1 | B_cargo | 18 | 66.5 | 1 | 0 | 0 | 0 | 0 | lissencephaly type 1 due to doublecortin gene mutation | 0.864453842605602 | |||
| Q8NCM8 | DYNC2H1 | Cytoplasmic dynein 2 heavy chain 1 | Tier 1.5 | 0.608 | 1 | B_cargo | 4 | 83.44 | 1 | 0 | 0 | 0 | 0 | asphyxiating thoracic dystrophy 3 | 0.8610362911667925 | |||
| O14746 | TERT | Telomerase reverse transcriptase | Tier 1 | 0.607 | 1 | B_cargo | 23 | 80.19 | 1 | 0 | 1 | 13 | 41104418, 40347637, 40062394, 39513874, 39441744, 37427434, 36005058, 35658460, 33476148, 28004350, 24176970, 22013508 | 0 | dyskeratosis congenita, autosomal dominant 2 | 0.8577919827748599 | ||
| Q9Y6K1 | DNMT3A | DNA (cytosine-5)-methyltransferase 3A | Tier 1 | 0.605 | 1 | B_cargo | 43 | 72.94 | 1 | 0 | 1 | 3 | 39079576, 31733056, 23179556 | 0 | acute myeloid leukemia | 0.8505245588442946 | ||
| Q3T906 | GNPTAB | N-acetylglucosamine-1-phosphotransferase subunits alpha/beta | Tier 1 | 0.605 | 1 | B_cargo | 5 | 71.62 | 1 | 0 | 0 | 0 | 0 | mucolipidosis type III, alpha/beta | 0.8490445308315259 | |||
| Q96RY7 | IFT140 | Intraflagellar transport protein 140 homolog | Tier 1 | 0.604 | 1 | B_cargo | 4 | 80.12 | 1 | 0 | 0 | 0 | 0 | short-rib thoracic dysplasia 9 with or without polydactyly | 0.8464676938353167 | |||
| P54098 | POLG | DNA polymerase subunit gamma-1 | Tier 1 | 0.604 | 1 | B_cargo | 36 | 78.94 | 1 | 0 | 0 | 0 | 0 | mitochondrial DNA depletion syndrome 4a | 0.8474167021250057 | |||
| O15360 | FANCA | Fanconi anemia group A protein | Tier 1 | 0.604 | 1 | B_cargo | 6 | 74.88 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group A | 0.8469248580955555 | |||
| Q92574 | TSC1 | Hamartin | Tier 1 | 0.604 | 1 | B_cargo | 5 | 62.06 | 1 | 0 | 1 | 1 | 18974095 | 0 | tuberous sclerosis | 0.8476796313298992 | ||
| Q2NKJ3 | CTC1 | CST complex subunit CTC1 | Tier 1 | 0.603 | 1 | B_cargo | 7 | 77.5 | 1 | 0 | 0 | 0 | 0 | Coats plus syndrome | 0.8438631461095314 | |||
| Q2M1P5 | KIF7 | Kinesin-like protein KIF7 | Tier 1.5 | 0.603 | 1 | B_cargo | 5 | 67.19 | 1 | 0 | 0 | 0 | 0 | acrocallosal syndrome | 0.8424257475739304 | |||
| O60931 | CTNS | Cystinosin | Tier 1.5 | 0.603 | 1 | B_cargo | 6 | 89.44 | 1 | 0 | 0 | 0 | 0 | nephropathic cystinosis | 0.841818398377195 | |||
| Q12879 | GRIN2A | Glutamate receptor ionotropic, NMDA 2A | Tier 1 | 0.602 | 1 | B_cargo | 37 | 60.84 | 1 | 0 | 0 | 0 | 0 | Landau-Kleffner syndrome | 0.8407159711916629 | |||
| P38398 | BRCA1 | Breast cancer type 1 susceptibility protein | Tier 1 | 0.602 | 1 | B_cargo | 33 | 41.59 | 1 | 0 | 1 | 13 | 40251554, 37288783, 36858016, 32945515, 32245065, 29737162, 28841982, 26784987, 24734899, 23836560, 21800393, 16825284 | 0 | breast cancer | 0.839035109761358 | ||
| Q9HBG6 | IFT122 | Intraflagellar transport protein 122 homolog | Tier 1.5 | 0.602 | 1 | B_cargo | 5 | 82.88 | 1 | 0 | 0 | 0 | 0 | cranioectodermal dysplasia | 0.8402296001002503 | |||
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | Tier 1 | 0.6 | 1 | B_cargo | 44 | 77.5 | 1 | 0 | 1 | 4 | 38467937, 37586882, 37422510, 36774388 | 0 | Hereditary late-onset Parkinson disease | 0.8349742982582067 | ||
| Q15910 | EZH2 | Histone-lysine N-methyltransferase EZH2 | Tier 1 | 0.6 | 1 | B_cargo | 38 | 76.25 | 1 | 0 | 1 | 8 | 41574287, 41223251, 40931580, 39853766, 36626902, 32884286, 30795863, 27719642 | 0 | Weaver syndrome | 0.8324078192564933 | ||
| Q9BXW9 | FANCD2 | Fanconi anemia group D2 protein | Tier 1.5 | 0.6 | 1 | B_cargo | 13 | 76.75 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group D2 | 0.8319139646572291 | |||
| Q05066 | SRY | Sex-determining region Y protein | Tier 1.5 | 0.599 | 1 | B_cargo | 10 | 67.62 | 1 | 0 | 1 | 1 | 40082426 | 0 | 46,XY sex reversal 1 | 0.8290523705747719 | ||
| Q96SD1 | DCLRE1C | Protein artemis | Tier 1 | 0.598 | 1 | B_cargo | 14 | 69.44 | 1 | 0 | 0 | 0 | 0 | severe combined immunodeficiency due to DCLRE1C deficiency | 0.826513936982479 | |||
| P48431 | SOX2 | Transcription factor SOX-2 | Tier 1 | 0.598 | 1 | B_cargo | 13 | 59.84 | 1 | 0 | 1 | 13 | 41377018, 40082426, 37891174, 37370863, 36284815, 34405338, 31991109, 31301870, 28988933, 26176230, 23892456, 18490265, 15863505 | 0 | anophthalmia/microphthalmia-esophageal atresia syndrome | 0.8263477268235936 | ||
| Q9Y253 | POLH | DNA polymerase eta | Tier 1 | 0.597 | 1 | B_cargo | 100 | 76.88 | 1 | 0 | 0 | 0 | 0 | xeroderma pigmentosum variant type | 0.8236705244099821 | |||
| Q9BYX4 | IFIH1 | Interferon-induced helicase C domain-containing protein 1 | Tier 1.5 | 0.597 | 1 | B_cargo | 9 | 79.44 | 1 | 0 | 1 | 1 | 18983163 | 0 | Aicardi-Goutieres syndrome 7 | 0.8235229759148853 | ||
| P40879 | SLC26A3 | Chloride anion exchanger | Tier 1 | 0.596 | 1 | B_cargo | 13 | 85.06 | 1 | 0 | 0 | 0 | 0 | congenital secretory chloride diarrhea 1 | 0.8189631913308207 | |||
| Q8NB91 | FANCB | Fanconi anemia group B protein | Tier 1 | 0.596 | 1 | B_cargo | 6 | 71.0 | 1 | 0 | 1 | 1 | 23836560 | 0 | Fanconi anemia | 0.8195998375932156 | ||
| Q9UJQ4 | SALL4 | Sal-like protein 4 | Tier 1 | 0.595 | 1 | B_cargo | 13 | 51.06 | 1 | 0 | 0 | 0 | 0 | Duane-radial ray syndrome | 0.8169322292438749 | |||
| P29033 | GJB2 | Gap junction beta-2 protein | Tier 1 | 0.594 | 1 | B_cargo | 24 | 86.19 | 1 | 0 | 0 | 0 | 0 | palmoplantar keratoderma-deafness syndrome | 0.8149616697051898 | |||
| Q9BQ52 | ELAC2 | Zinc phosphodiesterase ELAC protein 2 | Tier 1 | 0.594 | 1 | B_cargo | 10 | 82.81 | 1 | 0 | 0 | 0 | 0 | combined oxidative phosphorylation defect type 17 | 0.8142476181884984 | |||
| P61244 | MAX | Protein max | Tier 1 | 0.593 | 1 | B_cargo | 12 | 81.31 | 1 | 0 | 1 | 288 | 41934996, 41833970, 41619462, 41469028, 41439640, 41422825, 41237904, 41213249, 41083647, 41002303, 40921876, 40905551, 40902004, 40864593, 40850274, 40840129, 40642767, 40491004, 40383336, 40356230, 40164941, 40097648, 40011207, 39923524, 39890743, 39852074, 39828650, 39630145, 39605530, 39566329, 39420595, 39360861, 39225197, 39117896, 39115976, 39103298, 39056617, 38968658, 38920574, 38907914, 38899396, 38846799, 38682443, 38573322, 38542416, 38385442, 38359718, 38348887, 38217658, 38103284 | 0 | pheochromocytoma | 0.8086574254358271 | ||
| Q9UPT6 | MAPK8IP3 | C-Jun-amino-terminal kinase-interacting protein 3 | Tier 1 | 0.593 | 1 | B_cargo | 5 | 62.03 | 1 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | 0.8115235837032309 | |||
| Q8WVM7 | STAG1 | Cohesin subunit SA-1 | Tier 1 | 0.592 | 1 | B_cargo | 20 | 78.56 | 1 | 0 | 0 | 0 | 0 | intellectual disability, autosomal dominant 47 | 0.8075622605545107 | |||
| Q5TBB1 | RNASEH2B | Ribonuclease H2 subunit B | Tier 1 | 0.592 | 1 | B_cargo | 4 | 76.31 | 1 | 0 | 0 | 0 | 0 | Aicardi-Goutières syndrome | 0.8070167548553762 | |||
| Q8IXJ9 | ASXL1 | Polycomb group protein ASXL1 | Tier 1.5 | 0.592 | 1 | B_cargo | 4 | 42.22 | 1 | 0 | 0 | 0 | 0 | Bohring-Opitz syndrome | 0.8082443730060624 | |||
| Q9NW38 | FANCL | E3 ubiquitin-protein ligase FANCL | Tier 1.5 | 0.592 | 1 | B_cargo | 8 | 91.31 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group L | 0.8062585405338945 | |||
| Q13635 | PTCH1 | Protein patched homolog 1 | Tier 1 | 0.591 | 1 | B_cargo | 16 | 73.88 | 1 | 0 | 0 | 0 | 0 | nevoid basal cell carcinoma syndrome | 0.8042006866265059 | |||
| Q09472 | EP300 | Histone acetyltransferase p300 | Tier 1 | 0.591 | 1 | B_cargo | 60 | 53.25 | 1 | 0 | 1 | 2 | 39429683, 28539359 | 0 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 0.8025866884926094 | ||
| Q03164 | KMT2A | Histone-lysine N-methyltransferase 2A | Tier 1 | 0.591 | 1 | B_cargo | 60 | 1 | 0 | 1 | 1 | 33606679 | 0 | Wiedemann-Steiner syndrome | 0.802084366673722 | |||
| Q9UJV9 | DDX41 | Probable ATP-dependent RNA helicase DDX41 | Tier 1 | 0.59 | 1 | B_cargo | 5 | 77.94 | 1 | 0 | 0 | 0 | 0 | DDX41-related hematologic malignancy predisposition syndrome | 0.8011142376308067 | |||
| Q7Z6J9 | TSEN54 | tRNA-splicing endonuclease subunit Sen54 | Tier 1 | 0.59 | 1 | B_cargo | 5 | 72.38 | 1 | 0 | 0 | 0 | 0 | pontocerebellar hypoplasia type 4 | 0.8013423073419832 | |||
| Q13415 | ORC1 | Origin recognition complex subunit 1 | Tier 1 | 0.59 | 1 | B_cargo | 14 | 67.38 | 1 | 0 | 0 | 0 | 0 | Ear-patella-short stature syndrome | 0.7989950785999808 | |||
| Q9NRG9 | AAAS | Aladin | Tier 1.5 | 0.59 | 1 | B_cargo | 2 | 75.25 | 1 | 0 | 1 | 2 | 39798364, 30768874 | 0 | triple-A syndrome | 0.8009946434571534 | ||
| P49917 | LIG4 | DNA ligase 4 | Tier 1 | 0.589 | 1 | B_cargo | 31 | 88.19 | 1 | 0 | 0 | 0 | 0 | LIG4 syndrome | 0.7958751373450337 | |||
| Q9NUX5 | POT1 | Protection of telomeres protein 1 | Tier 1 | 0.589 | 1 | B_cargo | 14 | 87.38 | 1 | 0 | 1 | 3 | 41867726, 25934589, 21772997 | 0 | tumor predisposition syndrome 3 | 0.7983039512174813 | ||
| P46020 | PHKA1 | Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Tier 1.5 | 0.589 | 1 | B_cargo | 10 | 81.69 | 1 | 0 | 0 | 0 | 0 | glycogen storage disease IXd | 0.7957863874816654 | |||
| Q8WX94 | NLRP7 | NACHT, LRR and PYD domains-containing protein 7 | Tier 1.5 | 0.589 | 1 | B_cargo | 3 | 82.25 | 1 | 0 | 0 | 0 | 0 | hydatidiform mole, recurrent, 1 | 0.7978415742308576 | |||
| Q96EX3 | DYNC2I2 | Cytoplasmic dynein 2 intermediate chain 2 | Tier 1 | 0.588 | 1 | B_cargo | 4 | 82.06 | 1 | 0 | 0 | 0 | 0 | Short rib-polydactyly syndrome, Verma-Naumoff type | 0.7942611241080781 | |||
| O96028 | NSD2 | Histone-lysine N-methyltransferase NSD2 | Tier 1 | 0.588 | 1 | B_cargo | 19 | 65.62 | 1 | 0 | 0 | 0 | 0 | Rauch-Steindl syndrome | 0.7919900106594773 | |||
| Q9UBR1 | UPB1 | Beta-ureidopropionase | Tier 1.5 | 0.588 | 1 | B_cargo | 2 | 97.0 | 1 | 0 | 0 | 0 | 0 | beta-ureidopropionase deficiency | 0.7918900848494692 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;